CHEK2 and cancer: There was no significant difference in the penetrance of CHEK2 PTV vs. PMV for cancers in MyCode (univariate HR: 1.06 [0.90-1.25], P-value=0.47) and the UKBB (adjusted HR 1.15 [95%CI 1.00-1.33], P-value: 0.05).